Table 2.
Demographics and clinical profiles
| Training data set | Testing data sets | ||||||
|---|---|---|---|---|---|---|---|
| HC | CM | HC | CM | EM | FM | ||
| N | 56 | 80 | 14 | 20 | 35 | N | 35 |
| Demographics | Demographics | ||||||
| Age (years) | 41.4 ± 8.3 | 39.4 ± 11.6 | 38.3 ± 11.7 | 36.2 ± 10.5 | 38.0 ± 11.8 | Age (years) | 42.5 ± 11.2 |
| Sex | 39F/17 M | 69F/11 M | 11F/3 M | 15F/5 M | 27F/8 M | Sex | 34F/1 M |
| Psychometrics | Psychometrics | ||||||
| HADS_A | 4.6 ± 3.5 | 8.4 ± 4.1 | 3.7 ± 2.5 | 9.7 ± 5.4 | 8.2 ± 4.3 | HADS_A | 9.8 ± 4.2 |
| HADS_D | 3.9 ± 3.0 | 6.3 ± 3.9 | 3.7 ± 2.9 | 7.6 ± 4.3 | 5.8 ± 3.2 | HADS_D | 7.6 ± 4.4 |
| Migraine profile | FM profile | ||||||
| Headache days (/month) | - | 20.1 ± 6.4 | - | 22.6 ± 6.2 | 6.6 ± 3.8 | WPI | 11.0 ± 5.0 |
| Disease duration (months) | - | 198.6 ± 144.2 | - | 182.9 ± 157.5 | 162.3 ± 129.2 | SSS | 7.1 ± 2.1 |
| Severity of last year (0–10) | - | 6.3 ± 2.1 | - | 6.1 ± 2.2 | 5.5 ± 2.1 | Painkiller use (days/month) | 2.0 ± 3.3 |
| MIDAS scores | - | 45.7 ± 61.2 | - | 51.1 ± 74.9 | 22.2 ± 28.3 | FIQR | 39.4 ± 18.1 |
HC Healthy control, CM Chronic migraine, EM Episodic migraine, FM Fibromyalgia, HADS Hospital anxiety and depression score, A Anxiety, D Depression, MIDAS Migraine disability assessment, WPI Widespread pain index, SSS Symptom severity scale, FIQR Revised fibromyalgia impact questionnaire